Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Avalere Health

    Website
    Email
    +44 20 3328 1840

    Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our team of 1,500+ experts combine their knowledge and expertise across our core disciplines—Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience Technology—to create the connections that make better health happen.

    We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, our experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives.

    No. 3 Booths Park, Booths Hall, Chelford Road, Knutsford, Cheshire, WA16 8GS, United Kingdom

    How we’re empowering our teams to fight healthcare inequality

    Welcoming Sheena Amin-Liebman as our new Diversity and Inclusion Director. Sheena will play a vital role in creating an inspiring environment that empowers staff to better guide its clients in...

    Fishawack Health appoints new CEO, Jonathan Koch

    Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.

    Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role

    Elizabeth Landon brings exceptional leadership from a career supporting and scaling people-based businesses in the professional services and non-profit sectors.

    Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

    Fishawack Health enhances its omnichannel capabilities with the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.

    Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

    Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant expertise in US, EU, and Asia-Pacific markets

    Fishawack acquires creative consultancy Blue Latitude Health

    The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy...

    Fishawack launches new website and introduces new structure for growth

    The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group's capabilities as well as...

    ALL PRESS RELEASES

    Archetypes: Rethinking go-to-market expectations to drive commercial success

    In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

    Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment

    Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

    The challenges of reimbursement and innovative pricing for cell and gene therapies

    Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

    Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

    Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

    5 ways we’re enhancing our services to support our clients in 2023

    Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023.

    Why it’s time to apply a payer lens to your early pipeline planning

    Value, evidence, and market access experts Jan McKendrick and Andrea Hamlin reveal why applying a payer lens early in the value assessment of pipeline assets is essential for driving commercial...

    The fast-paced future of cell and gene therapies

    In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist...

    Omnichannel scientific engagement and the use of archetypes to drive personalization

    Natasha Cowan, Senior Corporate Communications Manager, explores with Gary Lyons, Head of Strategy, his recent plenary session at the 18th Annual ISMPP conference that focused on how scientific communicators can...

    The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

    With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

    Report: Reinventing product and portfolio value for the biopharmaceutical industry

    Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...

    ALL WHITE PAPERS

    Company Details

    - PMLiVE

    Email
    Website

     Latest Content from  Avalere Health 

    Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs

    Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.

    Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient

    As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.

    Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities

    As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.

    Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies

    Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.

    Archetypes: Rethinking go-to-market expectations to drive commercial success

    In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

    Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer

    Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.

    Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment

    Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

    The challenges of reimbursement and innovative pricing for cell and gene therapies

    Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

    Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

    Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

    Fishawack Health welcomes Mario Muredda as its new President of Marketing

    Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.